Tytuł pozycji:
MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells
-
Tytuł:
-
MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells
-
Autorzy:
-
Das, A.
Henderson, Jr, F. C.
Alshareef, M.
Porto, G. B. F.
Kanginakudru, I.
Infinger, L. K.
Vandergrift, III, W. A.
Lindhorst, S. M.
Varma, A. K.
Patel, S. J.
Cachia, D.
-
Źródło:
-
Clinical and Translational Oncology. 23(3):612-619
-